What was the controversy surrounding the NSAID Vioxx being pulled from the market by the FDA?
Answer: As an anti-inflammatory, Vioxx produced half as many gastric ulcers as non-specific inhibitors such as aspirin, and did not inhibit aggregation of blood platelets like aspirin, but Vioxx was pulled from the market when it became clear that Vioxx actually increased the risk of heart attack relative to placebo
If the answers is incorrect or not given, you can answer the above question in the comment box. If the answers is incorrect or not given, you can answer the above question in the comment box.